Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies
|
List Price: $139.00
Our Price: $110.66
Your Save: $ 28.34 ( 20% )
Availability: Usually ships in 24 hours
|
Manufacturer: Springer
|
Click on the Buy From Amazon.com link to know Amazon.com's best price & availability.
|
|
Binding: Hardcover
Dewey Decimal Number: 616.994
EAN: 9780387229492
ISBN: 0387229493
Label: Springer
Manufacturer: Springer
Number Of Items: 1
Number Of Pages: 854
Publication Date: 2005-06-14
Publisher: Springer
Studio: Springer
|
|
|
|
|
|
Editorial Reviews for Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies
|
Malignant mesothelioma is a rare form of cancer in which the cancer cells are found in the sac lining the chest (pleura) or abdomen (peritoneum). This lethal disease is associated with asbestos and has vast economic and legal implications. As the disease takes approximately twenty years to manifest itself in humans, a wave of diagnoses are expected in the near future. In the United States alone, an estimated 3,500 - 4,000 patients are diagnosed with mesothelioma annually, and it is estimated that over the next 35 years, more than 250,000 people in Western Europe will be diagnosed with the disease. Malignant Mesothelioma, edited by internationally recognized experts in the field, is a comprehensive text that relates science, pathology, clinical aspects and therapy for mesothelioma under one cover. The book integrates the newest research and advances in its discussions of the disease, covering such topics as carcinogenesis, epidemiology, benchwork, endoscopy, multimodality approaches and treatment. It includes discussions on novel approaches to mesothelioma, such as gene therapy, vaccination strategies and immunotherapy, as well as discussions on the legal and economic aspects of the disease. Over 200 illustrations round out the text. An invaluable reference for the medical oncologist, thoracic surgeon, radiation oncologist, pulmonologist, and benchworker interested in the disease.
|
|
|
|
|
|
|
|
|
More Information on Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies
Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and ...
Malignant Mesothelioma, edited by internationally recognized experts in the field, is a comprehensive text that relates science, pathology, clinical aspects and therapy for ...
NEJM -- Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis ...
Book Review from The New England Journal of Medicine -- Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies
Mesothelioma Cancer: Treatment, Symptoms, Support, Asbestos Lawsuits ...
... Assessment, Epidemiology, and Health Effects; Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies; A Phase II Study of the Association of Glivec ...
Information about Mesothelioma
Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies ... Mesothelioma Article. Mesothelioma Staging. ...
Mesothelioma News
Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies ... What to Expect in a Mesothelioma Case or Trial
NEJM -- Table of Contents (March 30 2006, 354 [13])
Listen to this week's Audio Summary ... Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies
Books by Harvey I. Pass M.D., expert in mesothelioma
Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies Harvey I. Pass, MD, Nicholas Vogelzang, Michele Carbone (Editors)
Harvey Pass, MD - NYU Department of Cardiothoracic Surgery
He also edited Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies and 100 Questions & Answers about Mesothelioma.
Mesothelioma
Mesothelioma by Bruce W. S. Robinson Malignant Mesothelioma : Advances in Pathogenesis, Diagnosis, and Translational Therapies by Harvey I. Pass et al
Mesothelioma Help
Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies by Harvey I. Pass, Nicholas Vogelzang, and Michele Carbone